Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01615731 · ClinicalTrials.gov registry record · NA
Value of Mifepristone in Cervical Preparation Prior to Dilation and Evacuation 19-24 Weeks
A NA study, sponsored by Stanford University.
- Completed
- Registry status
- NA
- Development phase
- 50
- Enrollment target
NCT01615731: Completed NA study, sponsored by Stanford University.
NCT01615731 is a NA study that has completed, run by Stanford University. The registered enrollment target is 50 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01615731, a NA study, has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- NA
- Development phase
- 50 participants
- Enrollment target
Study Summary
A common practice for preparation for surgical abortion after 19 weeks gestation is the placement of multiple sets of osmostic dilators 1-2 days prior to the procedure. The investigators aim to study the addition of mifepristone as an adjunct to cervical dilation prior to abortion between 19-24 weeks gestation, and its potential to minimize the number of painful procedures and time in clinic (or away from work/home) that multiple sets of dilators can require. The investigators hypothesize that one set of dilators with mifepristone will result in similar procedure times and decreased "total" time as two sets of dilators.
Interventions
- DRUG Mifepristone
- DRUG Misoprostol
- OTHER Hygroscopic cervical dilators
- DRUG Intra-amniotic digoxin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2012-05 |
| Est. Completion | 2013-07 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01615731
The ClinicalTrials.gov registry entry for NCT01615731 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Mifepristone is the first listed.
NCT01615731 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01615731 about?
NCT01615731 is a clinical study titled "Value of Mifepristone in Cervical Preparation Prior to Dilation and Evacuation 19-24 Weeks". A common practice for preparation for surgical abortion after 19 weeks gestation is the placement of multiple sets of osmostic dilators 1-2 days prior to the procedure. The investigators aim to study the addition of mifepristone as an adjunct to cervical dilation prior to abortion between 19-24 week...
What is the current status of trial NCT01615731?
This trial is currently completed. It is a NA study. The enrollment target is 50 participants. The study started on 2012-05. Estimated completion is 2013-07.
What interventions are being tested in trial NCT01615731?
The interventions under investigation include: Mifepristone (DRUG), Misoprostol (DRUG), Hygroscopic cervical dilators (OTHER), Intra-amniotic digoxin (DRUG).
Who is sponsoring clinical trial NCT01615731?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.